MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    FDG PET and MIBG scintigraphy in the differential diagnosis of parkinsonism: a head-to-head comparison

    N. Schröter, J. Brumberg, G. Blazhenets, L. Frings, J. Volkmann, C. Lapa, W. Jost, I. Isaias, P. Meyer (Freiburg, Germany)

    Objective: To compare the performance of [18F]fluorodeoxyglucose (FDG) PET and [123I]metaiodobenzylguanidine (MIBG) scintigraphy in the differential diagnosis of parkinsonism in the same patient sample. Background:…
  • MDS Virtual Congress 2020

    Brain atrophy progression in de novo Parkinson’s disease

    C. Tremblay, S. Rahayel, A. Vo, A. Dagher (Montreal, QC, Canada)

    Objective: Using deformation-based morphometry (DBM) as a measure of atrophy, the aim of this study was to identify the regions presenting structural brain changes after…
  • MDS Virtual Congress 2020

    Differentiating Parkinson’s disease dementia and mild cognitive impairment from idiopathic Parkinson’s disease using machine learning approach

    A. Bhattacharya, N. Kamble, A. S, V. N, A. Stezin, S. Hegde, A. J, R. Yadav, P. Pal (Bengaluru, India)

    Objective: This paper aims at creating a computer-based diagnosis tool which can predict the classification of MCI and dementia in patients of Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Motor asymmetry in Parkinson’s disease: relation with freezing of gait

    Z. Katzir, G. Zeilig, S. Israeli-Korn, S. Hassin-Baer, M. Plotnik (Ramat Gan, Israel)

    Objective: To evaluate the relation between motor symptoms asymmetry in patients with Parkinson’s disease (PD) and freezing of gait (FOG) episodes. Background: It is yet…
  • MDS Virtual Congress 2020

    The effect of severity of Parkinson’s disease on chronic headache

    J.Y Ahn, H.T Kim (Seoul, Republic of Korea)

    Objective: In this study, we sought to find out how PD affects to chronic headache. Background: Relationship between headache and Parkinson’s disease(PD) is not well…
  • MDS Virtual Congress 2020

    Loss of Weight Associated with Levodopa / Carbidopa Intestinal Gel

    A. Contreras, M. Carrascal, I. Bretón, F. Grandas (Madrid, Spain)

    Objective: To define the prevalence and severity of WL in patients of the Movement Disorders Unit of our center treated with LCIG and to analyze…
  • MDS Virtual Congress 2020

    Prevalence of apathy in Indian patients with Parkinson’s disease and its correlation with nigrosomal imaging

    R. Kandadai, P. Reddy, A. Arora, S. Meka, T. Syed, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To assess the prevalence of apathy in patients with patients with Parkinson's disease and to correlate it with nigrosomal imaging in a subset of…
  • MDS Virtual Congress 2020

    Is acoustic speech analysis applicable for evaluation of swallowing impairment in patients with Parkinson’s disease (PD)?

    N. Madetko, S. Budrewicz (Wrocław, Poland)

    Objective: More than 80% of patients with Parkinson’s disease develop dysphagia during the course of the disease. Methods considered as ‘gold standard’ in swallowing evaluation…
  • MDS Virtual Congress 2020

    Effects of Co-Morbidities on Sleep Patterns in Parkinson’s Disease: A Study of 84 Ibadan Patients

    R. Oguntoye (Ibadan, Nigeria)

    Objective: To assess the effects of co-morbidities on sleep patterns in PD. Background: Parkinson’s disease is a progressive neurodegenerative disease. The non-motor symptoms are said…
  • MDS Virtual Congress 2020

    The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience

    K. Rukavina, M. Krbot Skoric, C. Borley, L. Batzu, A. Rizos, D. van Wamelen, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine the usefulness of patient related outcome (PRO) measures in highlighting non-declaration of pain, a challenging non-motor symptom (NMS) of Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley